Urogen Pharma Ltd (URGN)

EBITDA Growth

93.51%

Quarterly · Period ending:

URGN logo

URGN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported93.51%
URGN Quarterly EBITDA YoY % (-483.66% → 93.51%)
High-resolution chart · PNG

URGN ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd EBITDA Growth — Quarterly
Period endingEBITDA Growth
93.5126%
51.1315%
15.4807%
-75.5313%
-64.6975%
-63.5652%
-253.6576%
-20.5353%
-49.0246%
9.2734%
69.7107%
44.6233%
-9.8228%
4.1165%
-26.0389%
26.0963%
28.8872%
-6.3965%
27.0093%
-3.9579%
18.6975%
31.1257%
31.1707%
-22.3961%
-32.212%
-66.7143%
-61.6667%
-11.2073%
-28.8854%
-66.9403%
-137.0297%
-7,253.4965%
-213.4891%
-283.6244%
-172.2357%
95.2751%
-74.6798%
1.9096%
301.8187%
-76.6369%
-483.6563%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.